Ajooni Biotech

Ajooni Biotech EBIT

The EBIT of Ajooni Biotech (AJOONI.NS) as of Oct 20, 2026 is 40.50 M INR. In the previous year, EBIT was 29.29 M INR — a change of 38.26% (higher).

EBIT

40.50 MINR

YoY

38.26%

Last updated:

In 2026, Ajooni Biotech's EBIT was 40.50 M INR, a 38.26% increase from the 29.29 M INR EBIT recorded in the previous year.

The Ajooni Biotech EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2019
5.41 M INR
Jan 1, 2020
7.68 M INR
Jan 1, 2021
10.88 M INR
Jan 1, 2022
19.75 M INR
Jan 1, 2023
17.64 M INR
Jan 1, 2024
35.53 M INR
Jan 1, 2025
29.29 M INR
Jan 1, 2026
40.50 M INR
The Ajooni Biotech EBIT history
YEAREBITYoY
40.50 MINR+38.26%
29.29 MINR-17.57%
35.53 MINR+101.47%
17.64 MINR-10.71%
19.75 MINR+81.51%
10.88 MINR+41.66%
7.68 MINR+41.97%
5.41 MINR-27.80%
7.49 MINR+43.03%
5.24 MINR+231.37%
1.58 MINR+48.73%
1.06 MINR+824.35%
115,000.00INR-1,377.78%
-9,000.00INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ajooni Biotech Revenue

Ajooni Biotech Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
397.18 M INR
5.41 M INR
4.11 M INR
Jan 1, 2020
400.33 M INR
7.68 M INR
3.47 M INR
Jan 1, 2021
510.39 M INR
10.88 M INR
3.73 M INR
Jan 1, 2022
740.38 M INR
19.75 M INR
10.49 M INR
Jan 1, 2023
744.88 M INR
17.64 M INR
11.25 M INR
Jan 1, 2024
801.15 M INR
35.53 M INR
21.61 M INR
Jan 1, 2025
1.15 B INR
29.29 M INR
32.38 M INR
Jan 1, 2026
1.82 B INR
40.50 M INR
43.22 M INR

Ajooni Biotech Margins

Ajooni Biotech stock margins

The Ajooni Biotech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Ajooni Biotech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Ajooni Biotech.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
8.17 %
1.36 %
1.03 %
Jan 1, 2020
12.79 %
1.92 %
0.87 %
Jan 1, 2021
15.73 %
2.13 %
0.73 %
Jan 1, 2022
13.54 %
2.67 %
1.42 %
Jan 1, 2023
11.74 %
2.37 %
1.51 %
Jan 1, 2024
12.19 %
4.43 %
2.70 %
Jan 1, 2025
12.04 %
2.55 %
2.82 %
Jan 1, 2026
15.17 %
2.22 %
2.37 %

Ajooni Biotech Stock analysis

What does Ajooni Biotech do? Ajooni Biotech Ltd, listed on the National Stock Exchange of India with ticker AJOONI.NS and ISIN INE820Y01021, is a company operating in the Consumer Staples sector, specifically within the Food Products industry. Headquartered in Mohali, Punjab, the company went public through an IPO on January 2, 2018. Ajooni Biotech focuses on the manufacturing, production, processing, and supply of cattle feed nutrients and animal health care supplements. The company offers a variety of products including compounded animal feed and feed supplements designed to support the entire life cycle of animals. Its product range encompasses cattle feed, cattle feed chips, camel feed, cotton oil cake, and mustard oil cake. The firm provides high-energy balanced cattle feed formulations such as calf starter, heifer, dairy calf grower, low yield cattle, basic milking cattle, and high yield cattle feeds. Specific product names mentioned include Autus DIAMOND WONDER, Autus NURTURE CALF STARTER, Autus WINNER, Autus HIFFER/GROWER, Autus ENERGY PLUS, Autus ECO, and Autus BUFF POWER. Additionally, the company supplies feed supplements like liquid calcium, liver tonic, mineral mixture, ultra-tonic, digestive powder, and multi vitamins, as well as products such as CALTUS, 4U, LIVTUS, RUMITUS, Mustmin, and AUTOVITA. The company's website is https://www.ajoonibiotech.com/. Ajooni Biotech is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Ajooni Biotech's EBIT

Ajooni Biotech's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Ajooni Biotech's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Ajooni Biotech's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Ajooni Biotech’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Ajooni Biotech stock

EBIT of Ajooni Biotech is 40.50 M INR in 2026.

EBIT of Ajooni Biotech changed from 29.29 M INR to 40.50 M INR, representing a 38.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Ajooni Biotech since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Ajooni Biotech historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Ajooni Biotech

All Key Metrics — Ajooni Biotech